Dynamk Capital
21
10M
12
3.50
6
0.43
1
- Stages of investment
- Areas of investment
Summary
Dynamk Capital is the famous VC, which was founded in 2016. The venture was found in North America in United States. The leading representative office of defined VC is situated in the New York.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Dynamk Capital, startups are often financed by Ventry Industries, The Thiel Foundation, National Institutes of Health. The meaningful sponsors for the fund in investment in the same round are Vanedge Capital, Third Kind Venture Capital, SV Angel. In the next rounds fund is usually obtained by Vanedge Capital, National Institutes of Health, Madrona Venture Group.
The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Chemical, Biotechnology. Among the various public portfolio startups of the fund, we may underline Envisagenics, Flodesign Sonics, RoosterBio
The increased amount of exits for fund were in 2019. The important activity for fund was in 2019. Comparing to the other companies, this Dynamk Capital performs on 9 percentage points less the average number of lead investments. Deals in the range of 5 - 10 millions dollars are the general things for fund. The real fund results show that this VC is 80 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 deals per year.
The fund was created by Daniella Kranjac. We also calculated 3 valuable employees in our database.
Investments analytics
Analytics
- Total investments
- 21
- Lead investments
- 6
- Exits
- 1
- Rounds per year
- 3.50
- Follow on index
- 0.43
- Investments by industry
- Biotechnology (14)
- Medical (8)
- Health Care (5)
- Life Science (4)
- Manufacturing (3) Show 11 more
- Investments by region
-
- United States (18)
- Switzerland (1)
- Norway (1)
- Canada (1)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 0.57
- Avg. company exit year
- 9
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Keyper | 16 May 2024 | Real Estate, Property Management, Advice, Innovation Management | Seed | 4M | Dubai, United Arab Emirates |
| Lucid Scientific | 05 Sep 2023 | Biotechnology, Medical, Product Research | Early Stage Venture | 7M | United States, Atlanta, Georgia |
| RoosterBio | 11 Sep 2019 | Biotechnology, Medical Device, Medical | Early Stage Venture | 6M | United States, Maryland, Frederick |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.